Attenuation of insulin secretion by insulin-like growth factor binding protein-1 in pancreatic β-cells

Biochemical and Biophysical Research Communications

Volumn 362, Issue 1, 2007, Pages 152-157

  Zhang, Fan ^a   Sjöholm, Åke ^a   Zhang, Qimin ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Cytosolic free Ca2+ concentration; Exocytosis; Insulin secretion; Insulin like growth factor; Insulin like growth factor binding protein 1; Islet; Somatostatin

Indexed keywords

CALCIUM ION; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOSTATIN; TOLBUTAMIDE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL FUNCTION; CONTROLLED STUDY; CYTOSOL; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SOMATOSTATIN RELEASE;

ANIMALS; CALCIUM; CYTOSOL; DIABETES MELLITUS, TYPE 2; EXOCYTOSIS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-SECRETING CELLS; MICE; MICE, OBESE; MODELS, BIOLOGICAL; NADP; SOMATOSTATIN;

EID: 34548094629     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.160     Document Type: Article

References (30)

1. George M., Ayuso E., Casellas A., Costa C., Devedjian J.C., and Bosch F. Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J. Clin. Invest. 109 (2002) 1153-1163
2. Xuan S., Kitamura T., Nakae J., Politi K., Kido Y., Fisher P.E., Morroni M., Cinti S., White M.F., Herrera P.L., Accili D., and Efstratiadis A. Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor. J. Clin. Invest. 110 (2002) 1011-1019
3. Firth S.M., and Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23 (2002) 824-854
4. Denley A., Cosgrove L.J., Booker G.W., Wallace J.C., and Forbes B.E. Molecular interactions of the IGF system. Cytokine Growth Factor Rev. 16 (2005) 421-439
5. Hwa V., Oh Y., and Rosenfeld R.G. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr. Rev. 20 (1999) 761-787
6. Underwood L.E., Thissen J.P., Lemozy S., Ketelslegers J.M., and Clemmons D.R. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm. Res. 42 (1994) 145-151
7. Kamoda T., Saitoh H., Inudoh M., Miyazaki K., and Matsui A. The serum levels of proinsulin and their relationship with IGFBP-1 in obese children. Diabetes Obes. Metab. 8 (2006) 192-196
8. Conover C.A., Lee P.D., Kanaley J.A., Clarkson J.T., and Jensen M.D. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J. Clin. Endocrinol. Metab. 74 (1992) 1355-1360
9. Murphy L.J. The role of the insulin-like growth factors and their binding proteins in glucose homeostasis. Exp. Diabesity Res. 4 (2003) 213-224
10. Wedrychowicz A., Dziatkowiak H., Nazim J., and Sztefko K. Insulin-like growth factor-1 and its binding proteins, IGFBP-1 and IGFBP-3, in adolescents with type-1 diabetes mellitus and microalbuminuria. Horm. Res. 63 (2005) 245-251
11. Hedman C.A., Frystyk J., Lindstrom T., Chen J.W., Flyvbjerg A., Orskov H., and Arnqvist H.J. Residual β-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes. J. Clin. Endocrinol. Metab. 89 (2004) 6305-6309
12. Mogul H.R., Marshall M., Frey M., Burke H.B., Wynn P.S., Wilker S., Southern A.L., and Gambert S.R. Insulin like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women. J. Clin. Endocrinol. Metab. 81 (1996) 4492-4495
13. Crossey P.A., Jones J.S., and Miell J.P. Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes 49 (2000) 457-465
14. Gay E., Seurin D., Babajko S., Doublier S., Cazillis M., and Binoux M. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth. Endocrinology 138 (1997) 2937-2947
15. Rajkumar K., Dheen S.T., and Murphy L.J. Hyperglycemia and impaired glucose tolerance in IGF binding protein-1 transgenic mice. Am. J. Physiol. 270 (1996) E565-E571
16. Schneider M.R., Lahm H., Wu M., Hoeflich A., and Wolf E. Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins. FASEB. J. 14 (2000) 629-640
17. Zhang Q., Berggren P.O., Larsson O., Hall K., and Tally M. Insulin-like growth factor II inhibits glucose-induced insulin exocytosis. Biochem. Biophys. Res. Commun. 243 (1998) 117-121
18. 2+ and insulin secretion. Am. J. Physiol. Cell Physiol. 291 (2006) C466-C475
19. 2+ release in insulin-secreting cells by ryanodine receptor tyrosine phosphorylation. Mol. Endocrinol. 18 (2004) 1658-1669
20. 2+ and the ATP/ADP ratio in pancreatic β-cells at substimulatory glucose. J. Biol. Chem. 278 (2003) 40710-40716
21. Dheen S.T., Rajkumar K., and Murphy L.J. Effects of insulin-like growth factors (IGF) on pancreatic islet function in IGF binding protein-1 transgenic mice. Diabetologia 39 (1996) 1249-1254
22. Kulkarni R.N., Holzenberger M., Shih D.Q., Ozcan U., Stoffel M., Magnuson M.A., and Kahn C.R. β-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass. Nat. Genet. 31 (2002) 111-115
23. Kulkarni R.N. Receptors for insulin and insulin-like growth factor-1 and insulin receptor substrate-1 mediate pathways that regulate islet function. Biochem. Soc. Trans. 30 (2002) 317-322
24. Ishihara H., Maechler P., Gjinovci A., Herrera P.L., and Wollheim C.B. Islet β-cell secretion determines glucagon release from neighbouring α-cells. Nat. Cell Biol. 5 (2003) 330-335
25. Wendt A., Birnir B., Buschard K., Gromada J., Salehi A., Sewing S., Rorsman P., and Braun M. Glucose inhibition of glucagon secretion from rat α-cells is mediated by GABA released from neighboring β-cells. Diabetes 53 (2004) 1038-1045
26. Lu Y., Herrera P.L., Guo Y., Sun D., Tang Z., LeRoith D., and Liu J.L. Pancreatic-specific inactivation of IGF-I gene causes enlarged pancreatic islets and significant resistance to diabetes. Diabetes 53 (2004) 3131-3141
27. Dumonteil E., Magnan C., Ritz-Laser B., Ktorza A., Meda P., and Philippe J. Glucose regulates proinsulin and prosomatostatin but not proglucagon messenger ribonucleic acid levels in rat pancreatic islets. Endocrinology 141 (2000) 174-180
28. Berelowitz M., Szabo M., Frohman L.A., Firestone S., Chu L., and Hintz R.L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212 (1981) 1279-1281
29. Goya L., de la Puente A., Ramos S., Martin M.A., Escriva F., and Pascual-Leone A.M. Regulation of insulin-like growth factor-I and -II by glucose in primary cultures of fetal rat hepatocytes. J. Biol. Chem. 274 (1999) 24633-24640
30. Horney M.J., Shirley D.W., Kurtz D.T., and Rosenzweig S.A. Elevated glucose increases mesangial cell sensitivity to insulin-like growth factor I. Am. J. Physiol. 274 (1998) F1045-F1053